Stocks close to their 52-week low
Stocks close to their 52-week low

Stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.8

The market opened in the red on June 12, 2020. The previous trading session witnessed the Sensex going down by 2.1 percent to end at 33,538 and the Nifty was down 2.1 percent to close at 9,902.

USFDA approves Biocon & Mylans Semglee
USFDA approves Biocon & Mylans Semglee

USFDA approves Biocon & Mylans Semglee

Apurva Joshi Article rating: 5.0

United States Food and Drug Administration (USFDA) granted approval to Semglee, an insulin glargine injection co-developed by Biocon Limited and Mylan N.V, which will be in vial and pre-filled pen presentations form used to keep in check high blood sugar in adults with type 2 diabetes, and adult and pediatric patients with type 1 diabetes.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 3.7

The market opened in the red on June 12, 2020, overall volumes in futures & options currently stand at 6.05 crore contracts with a turnover of Rs. 31,64,014.52 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.2

The market opened in the red on June 12, 2020, overall volumes in futures & options currently stand at 6.05 crore contracts with a turnover of Rs. 31,64,014.52 crore.

Parag Milk Foods: Promoters continue to release pledged shares
Parag Milk Foods: Promoters continue to release pledged shares

Parag Milk Foods: Promoters continue to release pledged shares

Nidhi Jani Article rating: 3.4

The promoters have released 15.5 lakh equity shares, which are in addition to the earlier release of 75 lakh equity shares pledged with Kotak Mahindra Investments that took place on April 23, 2020, by paying Rs 54 crore. This payment has been made towards the loan amounting to Rs 64 crore.

Lupin receives USFDA approval for Albendazole Tablets USP
Lupin receives USFDA approval for Albendazole Tablets USP

Lupin receives USFDA approval for Albendazole Tablets USP

Anthony Fernandes Article rating: 3.9

Thursday brought with it an announcement from pharma company, Lupin Limited stating that it had been granted approval by United States Food and Drug Administration (USFDA) for Albendazole Tablets USP, 200 mg.

Wipro partners with CloudKnox Security, enhancing cloud security
Wipro partners with CloudKnox Security, enhancing cloud security

Wipro partners with CloudKnox Security, enhancing cloud security

Anthony Fernandes Article rating: 5.0

IT company, Wipro Limited declared its tie-up with CloudKnox Security, a cybersecurity start-up, to enable enterprises to proactively safeguard and manage their hybrid and multi-cloud infrastructure by detecting and remediating over-permissioned identities.

Protect your capital first!
Protect your capital first!

Protect your capital first!

Shashikant Singh Article rating: 4.4

There is a high correlation between downward protection and long-term outperformance. This is because protecting from losses in the falling markets leaves more capital to grow than when the market rises again.

Index trend and stocks in action on June 12, 2020
Index trend and stocks in action on June 12, 2020

Index trend and stocks in action on June 12, 2020

Karan Dsij Article rating: 4.0

Nifty has witnessed a distribution day as it ended with sharp losses on the back of higher volume as compared to its prior session. Traders are advised not to venture into aggressive long position as long as the index stays below this level. Stocks in news: Biocon, SBI Life Insurance, Wipro, Lupin. 

RSS
First21162117211821192121212321242125Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR